MDGL logo

Madrigal Pharmaceuticals (MDGL) Working capital

annual working capital:

$863.65M+$344.92M(+66.49%)
December 31, 2024

Summary

  • As of today (June 23, 2025), MDGL annual working capital is $863.65 million, with the most recent change of +$344.92 million (+66.49%) on December 31, 2024.
  • During the last 3 years, MDGL annual working capital has risen by +$668.80 million (+343.25%).
  • MDGL annual working capital is now at all-time high.

Performance

MDGL Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLbalance sheet metrics

quarterly working capital:

$820.74M-$42.91M(-4.97%)
March 31, 2025

Summary

  • As of today (June 23, 2025), MDGL quarterly working capital is $820.74 million, with the most recent change of -$42.91 million (-4.97%) on March 31, 2025.
  • Over the past year, MDGL quarterly working capital has dropped by -$138.87 million (-14.47%).
  • MDGL quarterly working capital is now -15.09% below its all-time high of $966.57 million, reached on June 30, 2024.

Performance

MDGL quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

MDGL Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+66.5%-14.5%
3 y3 years+343.3%+467.9%
5 y5 years+108.1%+113.9%

MDGL Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+343.3%-15.1%+1310.4%
5 y5-yearat high+343.3%-15.1%+1310.4%
alltimeall timeat high+1865.7%-15.1%+1084.7%

MDGL Working capital History

DateAnnualQuarterly
Mar 2025
-
$820.74M(-5.0%)
Dec 2024
$863.65M(+66.5%)
$863.65M(-2.5%)
Sep 2024
-
$885.82M(-8.4%)
Jun 2024
-
$966.57M(+0.7%)
Mar 2024
-
$959.61M(+85.0%)
Dec 2023
$518.73M(+111.3%)
$518.73M(+282.0%)
Sep 2023
-
$135.80M(-32.7%)
Jun 2023
-
$201.89M(-13.3%)
Mar 2023
-
$232.94M(-5.1%)
Dec 2022
$245.47M(+26.0%)
$245.47M(+321.8%)
Sep 2022
-
$58.19M(-55.4%)
Jun 2022
-
$130.54M(-9.7%)
Mar 2022
-
$144.53M(-25.8%)
Dec 2021
$194.85M(-18.3%)
$194.85M(-16.6%)
Sep 2021
-
$233.63M(-13.3%)
Jun 2021
-
$269.36M(+3.9%)
Mar 2021
-
$259.25M(+8.7%)
Dec 2020
$238.61M(-42.5%)
$238.61M(-17.2%)
Sep 2020
-
$288.24M(-15.6%)
Jun 2020
-
$341.33M(-11.1%)
Mar 2020
-
$383.78M(-7.5%)
Dec 2019
$415.07M(-12.9%)
$415.07M(-5.6%)
Sep 2019
-
$439.86M(-3.6%)
Jun 2019
-
$456.47M(-2.5%)
Mar 2019
-
$467.93M(-1.9%)
Dec 2018
$476.76M(+162.0%)
$476.76M(-1.2%)
Sep 2018
-
$482.66M(-0.7%)
Jun 2018
-
$485.84M(+174.6%)
Mar 2018
-
$176.91M(-2.8%)
Dec 2017
$181.96M(+399.8%)
$181.96M(+235.7%)
Sep 2017
-
$54.20M(-11.9%)
Jun 2017
-
$61.51M(+78.6%)
Mar 2017
-
$34.45M(-5.4%)
Dec 2016
$36.41M(-174.4%)
$36.41M(-2.3%)
Sep 2016
-
$37.28M(-10.1%)
Jun 2016
-
$41.47M(-5.7%)
Mar 2016
-
$43.96M(-189.9%)
Dec 2015
-$48.91M
-$48.91M(-182.1%)
Sep 2015
-
$59.59M(-12.4%)
DateAnnualQuarterly
Jun 2015
-
$68.02M(+44.6%)
Mar 2015
-
$47.05M(-31.3%)
Dec 2014
$68.46M(+14.0%)
$68.46M(-23.3%)
Sep 2014
-
$89.23M(+9.3%)
Jun 2014
-
$81.66M(+70.0%)
Mar 2014
-
$48.03M(-20.0%)
Dec 2013
$60.03M(-22.9%)
$60.03M(+108.4%)
Sep 2013
-
$28.81M(-44.3%)
Jun 2013
-
$51.77M(-31.3%)
Mar 2013
-
$75.32M(-3.3%)
Dec 2012
$77.90M(+209.9%)
$77.90M(+110.7%)
Sep 2012
-
$36.98M(+35.7%)
Jun 2012
-
$27.24M(-35.7%)
Mar 2012
-
$42.35M(+68.5%)
Dec 2011
$25.14M(-27.7%)
$25.14M(-28.0%)
Sep 2011
-
$34.91M(-27.8%)
Jun 2011
-
$48.37M(+106.3%)
Mar 2011
-
$23.44M(-32.6%)
Dec 2010
$34.78M(+23.8%)
$34.78M(-12.7%)
Sep 2010
-
$39.85M(+7.4%)
Jun 2010
-
$37.11M(-19.1%)
Mar 2010
-
$45.89M(+63.3%)
Dec 2009
$28.11M(-51.5%)
$28.11M(-20.1%)
Sep 2009
-
$35.18M(-142.2%)
Jun 2009
-
-$83.35M(-293.7%)
Mar 2009
-
$43.02M(-25.7%)
Dec 2008
$57.90M(-39.8%)
$57.90M(+0.3%)
Sep 2008
-
$57.71M(-4.2%)
Jun 2008
-
$60.26M(-25.4%)
Mar 2008
-
$80.75M(-16.1%)
Dec 2007
$96.22M(+166.7%)
$96.22M(+162.3%)
Sep 2007
-
$36.69M(-26.7%)
Jun 2007
-
$50.05M(-25.4%)
Mar 2007
-
$67.06M(+85.8%)
Dec 2006
$36.08M(-25.6%)
$36.08M(-25.5%)
Sep 2006
-
$48.45M(-0.1%)
Dec 2005
$48.48M(-57.2%)
$48.48M(-49.1%)
Mar 2005
-
$95.22M
Dec 2004
$113.15M(+53.8%)
-
Dec 2003
$73.56M
-

FAQ

  • What is Madrigal Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual working capital year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly working capital year-on-year change?

What is Madrigal Pharmaceuticals annual working capital?

The current annual working capital of MDGL is $863.65M

What is the all time high annual working capital for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual working capital is $863.65M

What is Madrigal Pharmaceuticals annual working capital year-on-year change?

Over the past year, MDGL annual working capital has changed by +$344.92M (+66.49%)

What is Madrigal Pharmaceuticals quarterly working capital?

The current quarterly working capital of MDGL is $820.74M

What is the all time high quarterly working capital for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly working capital is $966.57M

What is Madrigal Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, MDGL quarterly working capital has changed by -$138.87M (-14.47%)
On this page